RNAimmune Competitors and Similar CompaniesClear all

Uvax Bio's competitors and similar companies include Stemirna, CureVac and RNACure.

	Uvax Bio Uvax Bio is a spin-off vaccine company that employs patented single-component self-assembling protein nanoparticle platform technology.	Stemirna Stemirna is an RNA technology-based drug development company.	CureVac CureVac is a biotechnology company offering messenger RNA (mRNA) technology.	RNACure RNACure is a company that develops a messenger RNA (mRNA) drug discovery platform made from mRNA synthesis.
Founding Date	Founding Date 2018	Founding Date 2016	Founding Date 2000	Founding Date 2019
Type	Type Private	Type Private	Type Public	Type Private
Tags	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development oncology pharma	Tags Healthcare biotech drug development pharma
Locations	Locations Wilmington, US HQ	Locations Shanghai, CN HQ	Locations Tübingen, DE HQ Ottignies Louvain La Neuve, BE Wiesbaden, DE Amsterdam, NL Basel, CH Boston, US	Locations Shanghai, CN HQ
Employees	Employees 1110% increase	Employees N/A	Employees 82517% decrease	Employees 5
Operating ⚠
Patent Applications	Patent Applications N/A	Patent Applications 2 (May, 2020)	Patent Applications 500 (Mar, 2020)	Patent Applications N/A
Patents Issued	Patents Issued 1 (May, 2020)	Patents Issued 2 (May, 2020)	Patents Issued 233 (May, 2020)	Patents Issued N/A
Platforms	Platforms N/A	Platforms 3 (May, 2020)	Platforms N/A	Platforms 2 (May, 2020)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 206.5m	Total funding raised $ 1.1b	Total funding raised N/A